Brief: Vaccitech Reports Third Quarter 2021 Financial Results And Recent Corporate Developments
Nov 12 (Reuters) - Vaccitech PLC VACC.O :
* VACCITECH REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
RECENT CORPORATE DEVELOPMENTS
* Q3 LOSS PER SHARE $0.13
* BELIEVES CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO FUND
OPERATIONS INTO FIRST HALF OF 2024
* Q3 EARNINGS PER SHARE VIEW $-0.45 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7tbwxy
Further company coverage: VACC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Barinthus Biotherapeutics
See all newsBrief: Barinthus Bio Provides Update On Proposed Combination With Clywedog Therapeutics
Brief: Barinthus Biotherapeutics PLC Appoints Douglas Swirsky As CFO And Principal Accounting Officer Effective May 1, 2026
Brief: Barinthus Bio Announces Update On Phase 1 AVALON Clinical Trial Of VTP-1000 For The Treatment Of Celiac Disease
Brief: Barinthus Bio Reports Second Quarter 2025 Financial Results And Updates On Corporate Developments
Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing